Skip to the page

Data / Form D filings / Thrombolex, Inc.

Thrombolex, Inc.: Form D filings

Thrombolex, Inc., a health care company in Kingston, NJ, filed 8 Form D notices with the SEC between 2017 and 2026. The latest, on March 12, 2026, reports $32.8 million sold of a $51.1 million offering to 22 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
4416 Route 27, Suite A, Kingston, NJ, 08528
Phone
(844) 792-6300
Industry
Other Health Care
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1703764

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Mar 12, 2026New notice$51,105,000$32,775,000$18,330,00022Feb 26, 2026sec.gov
Jun 21, 2024New notice$5,000,000$1,160,000$3,840,0005Jun 4, 2024sec.gov
May 28, 2024New notice$4,839,829$4,839,82956Jun 1, 2023sec.gov
Aug 30, 2022New notice$2,015,761$2,015,76150Jul 28, 2022sec.gov
Nov 29, 2021New notice$5,020,779$5,020,77946Nov 15, 2021sec.gov
Feb 3, 2020AmendmentIndefinite$9,819,88233Apr 6, 2017sec.gov
Apr 17, 2018AmendmentIndefinite$3,540,00019Apr 6, 2017sec.gov
Apr 17, 2017New notice$1,500,000$400,000$1,100,0001Apr 6, 2017sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Michael J. CerminaroExecutive Officer, Director
Marvin WoodallExecutive Officer, Director
John CerminaroExecutive Officer
Paul A. StewartDirector
David BonitaDirector
Sam LiangDirector
Keegan HarperDirector
Clay DeMarcusDirector

Other health care companies in New Jersey that filed recently

Every Form D from the week of Mar 9, 2026 · All recent filings in New Jersey · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what Thrombolex, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.